Navigation Links
Big Win for Biodiesel: ASTM Approves New Biodiesel Blend Specifications
Date:6/20/2008

Automakers, Fleets Encouraged by New Biodiesel Standards

VANCOUVER, British Columbia, June 20 /PRNewswire/ -- The biodiesel industry is celebrating today following last night's final vote by the ASTM International D02 Main Committee to approve a trio of long-awaited ASTM specifications for biodiesel blends. After more than five years of extensive research and subsequent balloting by the ASTM fuel experts in the blended fuel balloting process, ASTM has finally voted to approve three key sets of biodiesel specifications that should significantly bolster automaker support and consumer demand for biodiesel:

- Changes to the existing B100 biodiesel blend stock specification (ASTM D6751)

- Finished specifications to include up to 5% biodiesel (B5) in the conventional petrodiesel specification (ASTM D975)

- A new specification for blends of between 6 percent biodiesel (B6) to 20 percent biodiesel (B20) for on and off road diesel.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080620/CLF034LOGO )

Automakers and engine manufacturers have been requesting a finished blend specification for B20 biodiesel blends for several years, with some citing the need for that spec as the single greatest hurdle preventing their full-scale acceptance of B20 use in their diesel vehicles.

Steve Howell, Chairman of the ASTM Biodiesel Task Force, said, "The new ASTM specifications for B6-B20 blends will aid engine manufacturers in their engine design and testing processes to optimize the performance of vehicles running on biodiesel. The new specifications will also help ensure that only the highest quality biodiesel blends are made available to consumers at the retail pump."

Automaker Chrysler LLC was instrumental in working with the ASTM task force toward B20 specification development and approval, having supported fleet use of B20 in its Dodge
'/>"/>

SOURCE National Biodiesel Board
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. FDA Approves GlaxoSmithKlines AVODART(R) in Combination with Tamsulosin for the Treatment of Symptomatic Enlarged Prostate
2. Arpida Annual General Meeting of Shareholders Approves All Board Proposals
3. FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceuticals TRELSTAR(R) DEPOT and TRELSTAR(R) LA
4. FDA Approves VYVANSE(TM) (lisdexamfetamine dimesylate), the First and Only Once-Daily Prodrug Stimulant to Treat ADHD in Adults
5. Maryland Approves Medicaid Reimbursement for ActiPatch(R)
6. Healthcare Coalition Approves Tools to Improve Patient Safety During Transitions of Care
7. Medicare Approves in Home Sleep Apnea Testing
8. 3SBio Inc. Approves Share Repurchase Program
9. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
10. FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder
11. FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich Corporation ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements ... expired on December 22, 2014, thereby completing the ... for the acquisition of the Company by Merck ... clearance satisfies another condition to closing the transaction, ...
(Date:12/22/2014)... 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, ... today announced positive topline safety and tolerability ... of SYN-004, the Company,s investigational oral beta-lactamase ... difficile (C. difficile) infection, antibiotic-associated diarrhea ...
(Date:12/22/2014)... 2014  ( www.competitivehealth.com ) — Competitive Health is ... review and advocacy service, has signed an agreement to ... discount health services marketplace. 63% of Americans ... they expected to pay. As part of an ongoing ... Savings is pleased to offer medical bill review and ...
(Date:12/19/2014)... PA (PRWEB) December 19, 2014 ... leading developer and manufacturer of needle-free injection technology, ... agreement with Immunomic Therapeutics, Inc. (“ITI”) for ITI ... device with its LAMP™ vaccine platform. , ... an exclusive Worldwide license to the Biojector®-2000 that ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3
... (Nasdaq: SQNM ) is very pleased to ... 2011;342:c7401) of a groundbreaking international study led by our ... of Hong Kong. Building on early work from the ... of a large-scale clinical study that validates a noninvasive, ...
... MAR, Calif., Jan. 12, 2011 iDiverse today announced that ... Scientific Advisory Board. "We are extremely pleased to ... John Burr, president and CEO of iDiverse. "Dr. Miller has ... commercialization of novel bio-based technologies that have greatly improved the ...
... SeqWright Inc., a world-wide leader in custom genomic ... strides to position itself as the Next-Generation Sequencing ... can be attributed to the company,s ability to ... in key genomics technologies. Building on this success, ...
Cached Biology Technology:Professor Dennis Lo Trisomy 21 Clinical Validation Study Published in British Medical Journal 2Carl A. Miller, PhD, Joins iDiverse's Business and Scientific Advisory Board 2SeqWright Continues Expansion of Next-Generation Sequencing Capabilities 2
(Date:12/17/2014)... , Dec. 16, 2014  Automation is ... this more evident than at international borders. Over ... document scanners have allowed veteran travelers to self ... Passport Control (APC) Kiosks at an increasing number ... globe. According to Maxine ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ... long-held beliefs about the condition and the best ways to ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... extinct in Europe 24,000 years ago, but until now the ... mitochondrial DNA sequences from 17 new fossil samples, and compared ... the decline of the cave bear started 50,000 years ago, ... change. "The decline in the genetic diversity of the ...
... University researcher has helped to locate and identify a gene ... terriers. This same gene may be responsible for a similar ... improved screening and diagnosis of the disease in dogs and ... both canines and humans. Dr. Natasha Olby, associate professor ...
... Spanish . A study led ... suggests that a water soluble extract of cinnamon, which ... with diabetes and heart disease. The ... Human Nutrition Research Center (BHNRC) operated by USDA,s ...
Cached Biology News:True causes for extinction of cave bear revealed 2Researchers find gene responsible for neurodegenerative disease in dogs, possibly in humans 2Researchers study cinnamon extracts 2